Related Experiment Video
Updated: Aug 18, 2026
Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
Published on: October 16, 2013
Unmasking of alpha1 adrenoceptor induced hypnogenic response from medial preoptic area
Ramalingam Vetrivelan1, Hruda Nanda Mallick, Velayudhan Mohan Kumar
1Department of Physiology, All India Institute of Medical Sciences, New Delhi 110029, India.
Abstract:
Earlier studies had indicated the possibility of the involvement of the alpha(1) adrenergic receptors on the medial preoptic (mPOA) neurons in hypnogenesis. Microinjection of alpha1 agonist methoxamine (0.05 microg) into the mPOA of the rats, maintained at an ambient temperature (Tamb) of 24 degrees C, did not produce any significant change in sleep-wakefulness (S-W), except for an arousal of short duration, which coincided with the steep fall in body temperature (Tb). It was probably not possible to elicit sleep, because of hypothermia simultaneously produced by this drug. To test this hypothesis, experiments were conducted in an environment where the effects of hypothermia could be partially compensated for. When the rats were allowed to select their Tamb, they moved over to a compartment having a higher Tamb of 30 degrees C, on administration of methoxamine into the mPOA. Simultaneously, there was induction of sleep, which lasted for 60 min. Thus, it was possible to demonstrate the hypnogenic action of methoxamine, which was masked by hypothermic action of the drug. The findings indicate that the alpha1 adrenergic receptors in the mPOA are involved in the induction of sleep.
Insights
Alpha1 adrenergic receptors in the medial preoptic area (mPOA) are key to sleep induction. When hypothermia was compensated, methoxamine administration into the mPOA successfully induced sleep in rats.
Area of Science:
- Neuroscience
- Sleep Research
Background:
- Previous research suggested alpha(1) adrenergic receptors in the medial preoptic area (mPOA) play a role in sleep induction (hypnogenesis).
- Direct microinjection of alpha1 agonists into the mPOA did not consistently induce sleep in prior studies.
Purpose of the Study:
- To investigate the hypnogenic potential of alpha1 adrenergic receptors in the mPOA.
- To determine if the hypothermic effects of alpha1 agonists mask their sleep-inducing properties.
Main Methods:
- Rats received microinjections of the alpha1 agonist methoxamine into the mPOA at a controlled ambient temperature (24°C).
- Subsequent experiments allowed rats to self-select ambient temperature, moving to a warmer environment (30°C) after methoxamine administration.
Main Results:
- Methoxamine injection at 24°C caused arousal and a drop in body temperature (Tb), but no significant change in sleep-wakefulness (S-W).
- When rats could select a warmer environment (30°C), methoxamine administration into the mPOA successfully induced sleep for 60 minutes.
- This demonstrates that the hypothermic side effect of methoxamine masked its sleep-inducing action.
Conclusions:
- Alpha1 adrenergic receptors within the mPOA are confirmed to be involved in the induction of sleep.
- Environmental temperature regulation is crucial for observing the hypnogenic effects of alpha1 agonists in the mPOA.
